These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11416232)

  • 21. Congenital adrenal hyperplasia: lessons from a multinational study.
    Frisch H; Waldhauser F; Lebl J; Solyom J; Hargitai G; Kovacs J; Pribilincova Z; Krzisnik C; Battelino T;
    Horm Res; 2002; 57 Suppl 2():95-101. PubMed ID: 12065936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of bone mineral density of the lumbar spine in patients with beta-thalassemia major with dual-energy x-ray absorptiometry and quantitative computed tomography: a comparison study.
    Angelopoulos NG; Katounda E; Rombopoulos G; Goula A; Kaltzidou V; Kaltsas D; Ioannis P; Tolis G
    J Pediatr Hematol Oncol; 2006 Feb; 28(2):73-8. PubMed ID: 16462577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth and pubertal characteristics in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Trinh L; Nimkarn S; New MI; Lin-Su K
    J Pediatr Endocrinol Metab; 2007 Aug; 20(8):883-91. PubMed ID: 17937061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia.
    Falhammar H; Filipsson Nyström H; Wedell A; Brismar K; Thorén M
    Eur J Endocrinol; 2013 Mar; 168(3):331-41. PubMed ID: 23211577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone turnover markers predict bone mass development in young adult men: a five-year longitudinal study.
    Darelid A; Nilsson M; Kindblom JM; Mellström D; Ohlsson C; Lorentzon M
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1460-8. PubMed ID: 25594863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone mineral density in girls with classical congenital adrenal hyperplasia due to CYP21 deficiency.
    Elnecave RH; Kopacek C; Rigatto M; Keller Brenner J; Sisson de Castro JA
    J Pediatr Endocrinol Metab; 2008 Dec; 21(12):1155-62. PubMed ID: 19189689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women.
    Chaki O; Yoshikata I; Kikuchi R; Nakayama M; Uchiyama Y; Hirahara F; Gorai I
    J Bone Miner Res; 2000 Aug; 15(8):1537-44. PubMed ID: 10934652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of an aromatase inhibitor in children with congenital adrenal hyperplasia: Impact of anastrozole on bone mineral density and visceral adipose tissue.
    Halper A; Sanchez B; Hodges JS; Dengel DR; Petryk A; Sarafoglou K
    Clin Endocrinol (Oxf); 2019 Jul; 91(1):124-130. PubMed ID: 31070802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term corticosteroid replacement and bone mineral density in adult women with classical congenital adrenal hyperplasia.
    King JA; Wisniewski AB; Bankowski BJ; Carson KA; Zacur HA; Migeon CJ
    J Clin Endocrinol Metab; 2006 Mar; 91(3):865-9. PubMed ID: 16278269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydrocortisone dosing during puberty in patients with classical congenital adrenal hyperplasia: an evidence-based recommendation.
    Bonfig W; Pozza SB; Schmidt H; Pagel P; Knorr D; Schwarz HP
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3882-8. PubMed ID: 19622620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogeneity in Spinal Bone Mineral Density Among Young Adults From Three Eastern Provincial Capital Cities in Mainland China.
    Cheng XG; Li K; Ou SX; Tang GY; Wang QQ; Wang C; Wang L; Tian W
    J Clin Densitom; 2017; 20(2):198-204. PubMed ID: 27140902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term Consequences of Congenital Adrenal Hyperplasia due to Classic 21-hydroxylase Deficiency in Adolescents and Adults.
    Kim JH; Choi JH; Kang E; Kim YM; Lee BH; Yoo HW
    Exp Clin Endocrinol Diabetes; 2017 Mar; 125(3):196-201. PubMed ID: 28073127
    [No Abstract]   [Full Text] [Related]  

  • 33. Bone Mineral Content and Density in Indian Children with Congenital Adrenal Hyperplasia.
    Ganesh R; Suresh N; Janakiraman L
    Indian Pediatr; 2018 Oct; 55(10):880-882. PubMed ID: 29941696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term follow-up of children with classic congenital adrenal hyperplasia: suggestions for age dependent treatment in childhood and puberty.
    Pijnenburg-Kleizen KJ; Thomas CMG; Otten BJ; Roeleveld N; Claahsen-van der Grinten HL
    J Pediatr Endocrinol Metab; 2019 Oct; 32(10):1055-1063. PubMed ID: 31573958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of long-term glucocorticoid therapy on bone mineral density of the patients with congenital adrenal hyperplasia.
    Ünal S; Alikaşifoğlu A; Özön A; Gönç N; Kandemir N
    Turk J Pediatr; 2020; 62(3):359-366. PubMed ID: 32558409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone density and metabolism in thalassaemia.
    Lala R; Chiabotto P; Di Stefano M; Isaia GC; Garofalo F; Piga A
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():785-90. PubMed ID: 10091147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Völkl TM; Simm D; Beier C; Dörr HG
    Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone density in young patients with congenital adrenal hyperplasia.
    Mora S; Saggion F; Russo G; Weber G; Bellini A; Prinster C; Chiumello G
    Bone; 1996 Apr; 18(4):337-40. PubMed ID: 8726391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs.
    Välimäki MJ; Tiihonen M; Laitinen K; Tähtelä R; Kärkkäinen M; Lamberg-Allardt C; Mäkelä P; Tunninen R
    J Bone Miner Res; 1994 May; 9(5):631-7. PubMed ID: 8053391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.